N'-hydroxy-6-[3-(3-methylisoxazol-5-yl)propoxy]pyridine-3-carboximidamide

Catalog No. :
ACAPFO210
CAS No. :
1105194-39-5
Molecular Formula :
C13H16N4O3
Molecular Weight :
276.30

IUPAC Name:(Z)-N'-hydroxy-6-(3-(3-methylisoxazol-5-yl)propoxy)nicotinimidamide

N'-hydroxy-6-[3-(3-methylisoxazol-5-yl)propoxy]pyridine-3-carboximidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$555.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-hydroxy-6-[3-(3-methylisoxazol-5-yl)propoxy]pyridine-3-carboximidamide
IUPAC Name(Z)-N'-hydroxy-6-(3-(3-methylisoxazol-5-yl)propoxy)nicotinimidamide
MDL No.MFCD16653045
Molecular FormulaC13H16N4O3
Molecular Weight276.30
SMILESN/C(C1=CC=C(OCCCC2=CC(C)=NO2)N=C1)=N\O
InChI KeyVAGAMWTXYDQBDB-UHFFFAOYSA-N
SynonymN-hydroxy-6-[3-(3-methylisoxazol-5-yl)propoxy]pyridine-3-carboximidamide;n-Hydroxy-6-(3-(3-methylisoxazol-5-yl)propoxy)nicotinimidamide;3-Pyridinecarboximidamide, N-hydroxy-6-[3-(3-methyl-5-isoxazolyl)propoxy]-
CAS No.1105194-39-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAPFO210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAPFO210 route product structure diagram
    ACAPFO2101105194-39-5
Inquiry

2. ACAPFO210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAPFO210 route product structure diagram
    ACAPFO2101105194-39-5
Inquiry

Comments (0)